Andrea Bellingeri

Andrea Bellingeri

Auto-generated profile, based on publicly available information

Andrea Bellingeri

Wound Care Clinic , IRCCS Policlinico San Matteo,Pavia, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2016 in Journal of Wound Care
Verified
Journal Article
Closed access
TBT. Bianchi
T. Bianchi
RWR.D. Wolcott
R.D. Wolcott
APA. Peghetti
A. Peghetti
DLD. Leaper
D. Leaper
KCK. Cutting
K. Cutting
GPG. Pomponio
G. Pomponio
The potential impact of biofilm on healing in acute and chronic wounds is one of the most controversial current issues in wound care. A significant amount of laboratory-based research has been carried out on this topic, however, in 2013 the European Wound Management Association (EWMA) pointed out the lack of guidance for managing biofilms in clinical practice and solicited the need for guidelines and further clinical research. In response to this challenge, the Italian Nursing Wound Healing Society (AISLeC) initiated a project which aimed to achieve consensus among a multidisciplinary and multiprofessional international panel of experts to identify what could be considered part of ‘good clinical practice’ with respect to the recognition and management of biofilms in acute and chronic wounds. The group followed a systematic approach, developed by the GRADE working group, to define relevant questions and clinical recommendations raised in clinical practice. An independent librarian retrieved and screened approximately 2000 pertinent published papers to produce tables of levels of evidence. After a smaller focus group had a multistep structured discussion, and a formal voting process had been completed, ten therapeutic interventions were identified as being strongly recommendable for clinical practice, while another four recommendations were graded as being ‘weak’. The panel subsequently formulated a preliminary statement (although with a weak grade of agreement): ‘provided that other causes that prevent optimal wound healing have been ruled out, chronic wounds are chronically infected’. All members of the panel agreed that there is a paucity of reliable, well-conducted clinical trials which have produced clear evidence related to the effects of biofilm presence. In the meantime it was agreed that expert-based guidelines were needed to be developed for the recognition and management of biofilms in wounds and for the best design of future clinical trials. This is a fundamental and urgent task for both laboratory-based scientists and clinicians Declaration of interest: David Leaper was a paid lecturer/consultant advisor within the last two years for Johnson and Johnson, CareFusion and Pfizer. Andrea Bellingeri, consultant advisor in the last two years for Coloplast, Angelini. Keith Cutting: has received honoraria as a member of speakers bureaus and advisory boards and received travel and accommodation expenses from a number of wound products companies. All the other authors have no conflict of interest to declare.

2 March 2016 in Journal of Wound Care
Verified
Journal Article
Closed access
ABA. Bellingeri
A. Bellingeri
FFF. Falciani
F. Falciani
PTP. Traspedini
P. Traspedini
AMA. Moscatelli
A. Moscatelli
ARA. Russo
A. Russo
APA. Peghetti
A. Peghetti
Objective: Research into surfactant solutions for the debridement of chronic wounds suggests that surfactants may support wound bed preparation (WBP) in chronic wounds, however their efficacy has not been evaluated in randomised controlled trials (RCTs). Our aim was to assess the clinical efficacy of a propylbetaine-polihexanide (PP) solution versus normal saline (NS) solution in WBP, assessing inflammatory signs and wound size reduction in patients with pressure ulcers (PUs) or vascular leg ulcers. Method: In a single-blinded randomised controlled trial (RCT) patients were randomly allocated to two groups and treated with either propylbetaine-polihexanide (PP) solution (Prontosan) or NS. Wounds were assessed using the Bates-Jensen wound assessment tool (BWAT). Assessments took place at inclusion (T0), day 7 (T1), day 14 (T2), day 21 (T3), and day 28 (T4). Outcomes were analysed using a two-tailed Student's t-test. Results: A total of 289 patients were included. Both groups had similar demographics, clinical status, and wound characteristics. Data analysis showed statistically significant differences between T0 and T4 for the following outcomes: BWAT total score, p=0.0248; BWAT score for inflammatory items, p=0.03; BWAT scores for wound size reduction (p=0.049) and granulation tissue improvement (p=0.043), all in favour of PP. The assessment of pain did not show any significant difference between the two groups. Conclusion: The study results showed significantly higher efficacy of the PP solution versus NS solution, in reducing inflammatory signs and accelerating the healing of vascular leg ulcers and PUs. This evidence supports the update of protocols for the care of chronic wounds. Declaration of interest: The authors have no conflict of interest regarding this research. This is an investigator initiated trial. B. Braun Milano SpA kindly provided the material under investigation for both treatment groups, and paid the Ethics Committees' application fees in all participating centres.

2 August 2016 in Journal of Wound Care
Verified
Journal Article
Closed access
Natascia MenniniNatascia Mennini
Natascia Mennini
AGA. Greco
A. Greco
ABA. Bellingeri
A. Bellingeri
FVF. De Vita
F. De Vita
FPF. Petrella
F. Petrella
Objective: There are no well-defined criteria for assessing the efficacy and quality of wound dressings, and evaluation is often simplistic and based on the subjective opinion of the health-care professional. The aim of this study was to identify specific parameters suitable for measuring dressings' performance, and to recommend laboratory tests able to evaluate these specific criteria in an objective manner. Method: After reviewing all tests currently used in Italy and examining the criteria for evaluating the quality of dressings, the authors selected 12 clinically significant parameters. These parameters were measured using standard and non-standard tests, and in some cases, these tests were modified and improved to simulate real-life conditions more accurately. Results: Most of the tests used were able to discriminate well between dressings belonging to different brands, with some tests being more suitable than others for the assessment of specific dressings. Conclusion: These results highlighted some issues in the standard testing procedures, such as the need of a suitable fluid that mimics the real exudate, and the importance of standard temperature and humidity conditions during testing. Our study paves the way for a larger project aimed at a systematic evaluation of dressing quality able to assess every wound dressing on the market.

14 June 2011 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
Marilena GregoriniMarilena Gregorini
Marilena Gregorini
MCMichela Castello
Michela Castello
TRTeresa Rampino
Teresa Rampino
ABAndrea Bellingeri
Andrea Bellingeri
GBGiovanni Borroni
Giovanni Borroni
ACAntonio Dal Canton
Antonio Dal Canton

12 August 2009
Verified
Journal Article
Closed access
APAngela Paghetti
Angela Paghetti
ABAndrea Bellingeri
Andrea Bellingeri
GPGiovanni Pomponio
Giovanni Pomponio
JSJulita Sansoni
Julita Sansoni
DPDario Paladino
Dario Paladino

14 June 2006
Verified
Book Chapter
Closed access
PDF file
ABAndrea Bellingeri
Andrea Bellingeri
DHDeborah Hofman
Deborah Hofman